From the superbug scare in Pennsylvania last month to the UK’s recently released Review on Antimicrobial Resistance, slowing the rate at which infections become resistant to antibiotics is rising up the list of global health priorities—and rightfully so. The Review estimates that deaths from antimicrobial resistance (AMR) could reach 10 million people a year by 2050 if we don’t reduce the overuse and misuse of antimicrobials, including antibiotics, and that the economic damage could add up to a staggering $100 trillion by 2050.
CGD Policy Blogs
- (-) Remove Sustainable Development Finance filter Sustainable Development Finance
- (-) Remove Global Health filter Global Health
- (-) Remove International Financial Institutions filter International Financial Institutions
- (-) Remove Financing for Outbreak Preparedness and Response filter Financing for Outbreak Preparedness and Response
- (-) Remove Antimicrobial Resistance filter Antimicrobial Resistance
June 28, 2016